Glaxosmithkline (GSK)

 

Latest News

Director/PDMR Shareholding

RNS Number: 2490U GlaxoSmithKline PLC 20 October 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Mr B McNamara b) Position/status CEO, Consumer Healthcare c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market pa...

Director/PDMR Shareholding

RNS Number: 2483U GlaxoSmithKline PLC 20 October 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Mr N Hirons b) Position/status SVP, Global Ethics & Compliance c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market p...

Director Deals - GlaxoSmithKline PLC (GSK)

Dr Patrick Vallance, Executive Director, has re-invested 9,295 shares in the company on the 12th October 2017 at a price of...

Director Deals - GlaxoSmithKline PLC (GSK)

Simon Dingemans, Financial Director, has re-invested 8,087 shares in the company on the 12th October 2017 at a price of 15...

All News

DateHeadlineSource
20-10-17Director/PDMR ShareholdingRNS
20-10-17Director/PDMR ShareholdingRNS
16-10-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
16-10-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
16-10-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
16-10-17Director/PDMR ShareholdingRNS
16-10-17Director/PDMR ShareholdingRNS
16-10-17Director/PDMR ShareholdingRNS
16-10-17Director/PDMR ShareholdingRNS
16-10-17FTSE falls as utility stocks weigh on performance StockMarketWire
16-10-17Oil and copper rally fail to boost FTSE StockMarketWire
16-10-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
16-10-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
16-10-17Director/PDMR ShareholdingRNS
16-10-17Director/PDMR ShareholdingRNS
16-10-17Broker Forecast - Jefferies International issues a broker note on GlaxoSmithKline PLCStockMarketWire
16-10-17GSK shingles vaccine gets first approval in Canada StockMarketWire
13-10-17GSK first approval of Shingrix in CanadaRNS
13-10-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
13-10-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
13-10-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
13-10-17Director/PDMR ShareholdingRNS
13-10-17Director/PDMR ShareholdingRNS
13-10-17Director/PDMR ShareholdingRNS
11-10-17Director/PDMR ShareholdingRNS
05-10-17Domestic cyclical stocks to buy and sellInteractive Investor
04-10-17Broker Forecast - Liberum Capital issues a broker note on GlaxoSmithKline PLCStockMarketWire
02-10-17Total Voting RightsRNS
25-09-17Director/PDMR ShareholdingRNS
20-09-17GSK and Innoviva report positive COPD results StockMarketWire
20-09-17Positive IMPACT results for Trelegy in COPDRNS
19-09-17FTSE gains supported by BP, Shell and sterling retreatStockMarketWire
19-09-17Trelegy Ellipta: FDA approval in COPD receivedRNS
18-09-17Investors to receive £8.2 billion dividend windfallInteractive Investor
15-09-17Trelegy Ellipta: positive opinion from CHMP EuropeRNS
14-09-17FDA committee recommends GSK shingles vaccine StockMarketWire
14-09-17Unanimous FDA approval for Shingrix in over 50sRNS
13-09-17Broker Forecast - JP Morgan Cazenove issues a broker note on GlaxoSmithKline PLCStockMarketWire
12-09-17Director/PDMR ShareholdingRNS
12-09-17GSK: phase III results on mepo in COPD in NEJMRNS

RSS feeds

  • Editorial news feed for LSE:GSK Editorial
  • Regulatory news feed for LSE:GSK Regulatory